Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2012; 18(30): 4004-4011
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004
Results | Reference |
All papers dealing with faecal M2-PK found in a literature search of Pubmed and Embase | [7, 8, 10,18, 20-49] |
Additional published studies known to the authors | [50-53] |
Excluded papers - reasons for exclusion | |
Unique combination of antibodies | [47] |
Reviews | [18, 24, 26, 28, 34, 38, 42] |
Author replies or comments | [27, 32, 40] |
Paper in Bulgarian language | [29] |
No sensitivities or specificities calculated | [21, 48] |
Studies referred to IBD | [20, 22, 23, 25, 36, 39, 43] |
Included papers | |
Studies found in Pubmed and Embase | [7, 8, 10, 30, 31, 33, 35, 37, 41, 44-46, 49] |
Published studies known to the authors | [50-53] |
- Citation: Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World J Gastroenterol 2012; 18(30): 4004-4011
- URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4004.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4004